Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocarnitine for Keratoconjunctivitis Sicca in Sjogren's Syndrome
NCT03953703Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Nov 2021
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levocarnitine in keratoconjunctivitis sicca (KCS), sponsored by Vanderbilt University Medical Center. Started Nov 2021; status: completed.
02
Drugs
levocarnitine
03
Conditions
keratoconjunctivitis sicca (KCS)
Beyond the preview
Go deeper on NCT03953703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03953703.